{"data":[{"accessionNo":"0001897612-26-000293","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001894562","issuerName":"PRIME MEDICINE INC","ticker":"PRME","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"T. Rowe Price Investment Management, Inc.","reportingCik":null,"personType":"IA","sharesOwned":5995183,"percentOfClass":3.3,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/prme"},{"accessionNo":"0001897612-25-000555","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001894562","issuerName":"PRIME MEDICINE INC","ticker":"PRME","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"T. Rowe Price Investment Management, Inc.","reportingCik":null,"personType":"IA","sharesOwned":9236955,"percentOfClass":5.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/prme"},{"accessionNo":"0001845041-25-000005","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001894562","issuerName":"Prime Medicine, Inc.","ticker":"PRME","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"XXVI Holdings Inc.","reportingCik":null,"personType":"CO","sharesOwned":16562498,"percentOfClass":12.3,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/prme"},{"accessionNo":"0001845041-25-000005","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001894562","issuerName":"Prime Medicine, Inc.","ticker":"PRME","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"Alphabet Holdings LLC","reportingCik":null,"personType":"OO","sharesOwned":16562498,"percentOfClass":12.3,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/prme"},{"accessionNo":"0001845041-25-000005","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001894562","issuerName":"Prime Medicine, Inc.","ticker":"PRME","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"Alphabet Inc.","reportingCik":null,"personType":"HC,CO","sharesOwned":16562498,"percentOfClass":12.3,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/prme"},{"accessionNo":"0001845041-25-000005","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001894562","issuerName":"Prime Medicine, Inc.","ticker":"PRME","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"GV 2019 GP, L.P.","reportingCik":null,"personType":"PN","sharesOwned":10100058,"percentOfClass":7.5,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/prme"},{"accessionNo":"0001845041-25-000005","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001894562","issuerName":"Prime Medicine, Inc.","ticker":"PRME","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"GV 2019, L.P.","reportingCik":null,"personType":"PN","sharesOwned":10100058,"percentOfClass":7.5,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/prme"},{"accessionNo":"0001845041-25-000005","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001894562","issuerName":"Prime Medicine, Inc.","ticker":"PRME","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"GV 2019 GP, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":10100058,"percentOfClass":7.5,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/prme"},{"accessionNo":"0001845041-25-000005","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001894562","issuerName":"Prime Medicine, Inc.","ticker":"PRME","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"GV 2023, L.P.","reportingCik":null,"personType":"PN","sharesOwned":3200000,"percentOfClass":2.4,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/prme"},{"accessionNo":"0001845041-25-000005","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001894562","issuerName":"Prime Medicine, Inc.","ticker":"PRME","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"GV 2021, L.P.","reportingCik":null,"personType":"PN","sharesOwned":3262440,"percentOfClass":2.4,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/prme"},{"accessionNo":"0001845041-25-000005","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001894562","issuerName":"Prime Medicine, Inc.","ticker":"PRME","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"GV 2021 GP, L.P.","reportingCik":null,"personType":"PN","sharesOwned":3262440,"percentOfClass":2.4,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/prme"},{"accessionNo":"0001845041-25-000005","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001894562","issuerName":"Prime Medicine, Inc.","ticker":"PRME","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"GV 2021 GP, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":3262440,"percentOfClass":2.4,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/prme"},{"accessionNo":"0001845041-25-000005","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001894562","issuerName":"Prime Medicine, Inc.","ticker":"PRME","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"GV 2023 GP, L.P.","reportingCik":null,"personType":"PN","sharesOwned":3200000,"percentOfClass":2.4,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/prme"},{"accessionNo":"0001845041-25-000005","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001894562","issuerName":"Prime Medicine, Inc.","ticker":"PRME","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"GV 2023 GP, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":3200000,"percentOfClass":2.4,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/prme"},{"accessionNo":"0000315066-25-002807","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001894562","issuerName":"PRIME MEDICINE INC","ticker":"PRME","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":6731796,"percentOfClass":3.8,"filedAt":"2025-11-05","canonicalUrl":"https://xoomar.com/markets/stocks/prme"},{"accessionNo":"0000315066-25-002807","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001894562","issuerName":"PRIME MEDICINE INC","ticker":"PRME","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":6731796,"percentOfClass":3.8,"filedAt":"2025-11-05","canonicalUrl":"https://xoomar.com/markets/stocks/prme"}],"updatedAt":"2026-11-04T03:20:18.787Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/prme","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}